NCR3 and leukemia: While CAR-TIM3 NK-like cells significantly upregulated an activating receptor CD161 in response to all tested TIM3-positive and negative leukemia cells when compared with WT NK-like cells, its effects on Nkp30 and CD158 were observed only in response to TIM3-negative K562 cells.